Applied DNA Sciences

No. 477: In which the Suffolk IDA incentivizes and the double helix debuts – plus, sticky buns for all!

  Just a word or two: Welcome to Friday, dear readers, as we wrap up another busy workweek and look forward to another well-earned weekend. It’s Feb. 21 out there, and before we begin, please speak up – today is International Mother Language Day, the U.N.’s multicultural salute to linguistic diversity. Going to extremes: Today is also National Grain-Free Day (a big one for the low-carb set) and National Sticky Buns Day (not so much)….


No. 475: Love is in the air – along with Ferris wheels, podcasts and ‘mega sports’

  We heart you: You’ve done it again, dear reader – another workweek conquered, another Friday reached, and for that, you have our undying affection. It’s Feb. 14 out there, which in addition to Valentine’s Day brings several annual celebrations: National Cream-Filled Chocolates Day (makes sense), National Condom Day (ditto) and Frederick Douglass Day (which you might not have thought of, but the famed abolitionist’s actual birthdate is unknown and he chose Feb. 14, so…


Higher revenues chip in as Veeco eyes ‘transformation’

  VEECO INSTRUMENTS INC. Headquarters: Oyster Bay Industry: Technology Nasdaq: VECO Reporting Date: Feb. 13, 2020 Reporting Quarter: 4Q FY2019 Quarter Ended: Dec. 31, 2019 Numbers: Fourth-quarter revenues were reported as $113.2 million, a 14.3 percent increase from the $99 million reported for the same quarter last fiscal year. The company also reported a fourth-quarter GAAP net loss of $32.9 million (69 cents per share), cutting down the $144.7 million loss ($3.11 per share) reported…


Applied DNA to speed up coronavirus countermeasures

By GREGORY ZELLER // Look out, coronavirus – Applied DNA is coming for you. Adding to its growing portfolio of cutting-edge Polymerase Chain Reaction-based projects, Stony Brook-based Applied DNA Sciences is expanding its Joint Development Agreement with Italian R&D company Takis Biotech, with the headline-making 2019-nCoV in their sights. Already hot on the trail of new cancer vaccines, the partners will now work on a “linear DNA” vaccine against the dreaded Wuhan, China-based illness that’s…


No. 449: Braving the rebrand, locking down opioids and building a better Manufacturers’ Symposium

  Almost there: You’ve made it this far, dear readers, and congratulations for that, as we wind down another busy workweek and look ahead to another well-earned autumnal weekend. Shoe ins: It’s Oct. 25 on Long Island and around the world, and before we dive in, welcome aboard new newsletter subscribers Judy, Michael, Wayne, Lee, Lloyd, Gordon, Holly, Maryellen, Raymond, Sai, Richard, Stephen, Eric and Tim. If any of you had Crispin and Crispian, the…


No. 448: In which the Earth ages, Applied DNA’s patents proliferate and Marvel gets super-Sirius

  Turning point: Welcome to Wednesday, dear readers, as we hurtle the hump and steam into the latter half of this latest busy workweek. Holy moly: It’s Oct. 23 out there, and you certainly don’t need us to tell you this, but it’s Mole Day, celebrated internationally (at 6:02 a.m. and 6:02 p.m. precisely) by chemists and design/tech types. Of course, at those times, on this date, in the American style of date-writing, it’s 6:02…


Pending patent a cellulosic score for Applied DNA

By GREGORY ZELLER // A Stony Brook-based biotech on the leading edge of DNA-based product authentication is about to add another U.S. patent to its growing collection. Applied DNA Sciences, which has raced to the front of the Polymerase Chain Reaction-based forensic-traceability field, has received a Notice of Allowance from the U.S. Patent and Trademark Office for its “Methods of Marking Cellulosic Products” – meaning its application to patent the technique has been allowed, and…


‘Linear DNA’ combo shows punch in cancer fight

By GREGORY ZELLER // Mark another impressive victory for LineaRX, this time in a two-front battle against cancer. The Stony Brook-based biotech with innovation in its DNA (literally) has lent its unique DNA-sequencing technology to two vaccine-candidate tests run by Italian R&D company Takis Biotech, which is hot on the trail of new therapeutic cancer vaccines. It might be catching up. On Thursday, LineaRX announced that both vaccines – each produced in “linear DNA” form…


No. 435: Kicking off, sinking vs. swimming and justice for all (fraud victims, that is)

  End run: Welcome to Friday, dear readers, and the last leg of this busy late-summer workweek. It’s Sept. 6 out there, and if you had the Mayflower departing Plymouth, England, and setting a course for history on this date in 1620, well done! A half-crown and two shillings for you; please contact our Awards Department for more information. Are you ready for some football? It’s Unification Day in Bulgaria and Armed Forces Day in…


Down is up at Applied DNA, with the good stuff

By GREGORY ZELLER // An aggressive Long Island biotech is getting down, literally, with another global textiles supplier. Stony Brook-based supply-chain security specialist Applied DNA Sciences announced Thursday a new sales and marketing partnership with Navarpluma, a premier supplier of down and feathers to worldwide textiles manufacturers. Financial terms of the deal were not disclosed, but this latest collaboration with an international partner will see Applied DNA’s SigNature DNA molecular-tracking system applied to Navarpluma’s products, which…


No. 430: Growing up fast, helping Northwell’s ‘dependents’ and plugging Innovation Park

  In country: You’ve done it again, intrepid innovator – another workweek in the books, another weekend on tap. It’s Aug. 16 on Long Island and around the world – and soon to be Friday Night in Dixie, as noted by Rhett Atkins. The hills are alive: To our readers in Kyoto, a blessed Gozan no Okuribi, the traditional Aug. 16 “send-off fire” concluding Japan’s annual Obon festival and ushering visiting spirits back to the…


No. 429: Classic cartoons, downtown dreams and the nitrogen nuisance – plus, it curves!

  Middle ground: It’s Wednesday, dear readers, and you’re halfway through this latest summery week of socioeconomic innovation. Keep it up. Today is Aug. 14, and if you had the real-life, rebellious Macbeth killing his cousin, King Duncan I (in battle, not in bed), and assuming the Scottish throne on this date in 1040, glè mhath! Here’s a voucher for 100 silver sceats, redeemable in the casino. Best laid plans: To our many readers in…


For Applied DNA, new blood – and a shot in the arm

By GREGORY ZELLER // Just 11 months after spinning off from its parent company, a Stony Brook startup with expansion in its DNA has made its first corporate acquisition. LineaRX, a subsidiary of Applied DNA Sciences, has acquired the physical assets and intellectual property of Vitatex Inc., a private biotech with close ties to Stony Brook University and a patented method of isolating Invasive Circulating Tumor Cells in standard blood samples – spotting metastatic cells…


No. 420: Wheels up in Suffolk, Alda’s new Discovery, a vagus wedding and the survey says…?

  You win: The Friday finish line approaches and you’ve done it again, dear reader – another steamy workweek in the books, another well-earned weekend on tap. It’s July 12 out there, and if you had the Ottoman Empire capturing Euboea in Central Greece on this date in 1470, finally ending the month-long Siege of Negroponte, aferin sana! Here’s your receipt for 50 silver akçe, redeemable anywhere on the third-floor promenade. Freshly squeezed: To our…


No. 419: Kittens, coladas, Tesla and DNA-infused inks – plus, dialing back the Nassau IDA

  Welcome back: Here we are, dear readers, back on the beat as Summer 2019 heats up and we hustle through another busy week of socioeconomic innovation on Long Island and around the world. It’s July 10 out there – both National Kitten Day and National Piña Colada Day, an undeniably sweet combination. Ssshhh: To our readers who are also devout followers of 20th century Indian avatar Meher Baba – who famously kept his mouth…